Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The ecosystem of health decision making: from fragmentation to synergy.

Autor: Schünemann HJ; Michael G. DeGroote Cochrane Canada Centre and McMaster GRADE Centres, Department of Health Research Methods, Evidence, and Impact, Department of Medicine, and WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, ON, Canada; Dipartimento di Scienze Biomediche, Humanitas University, Milan, Italy. Electronic address: schuneh@mcmaster.ca., Reinap M; Division of Country Health Policies and Systems, WHO Regional Office for Europe, Copenhagen, Denmark., Piggott T; Michael G. DeGroote Cochrane Canada Centre and McMaster GRADE Centres, Department of Health Research Methods, Evidence, and Impact, Department of Medicine, and WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, ON, Canada., Laidmäe E; Department of Medicines and Medical Devices, Estonian Health Insurance Fund, Tallinn, Estonia., Köhler K; WHO Country Office in Estonia, World Health Organization, Tallinn, Estonia., Pōld M; Institute of Family Medicine and Public Health, Health Technology Assessment Unit, University of Tartu, Tartu, Estonia., Ens B; Canadian Agency for Drugs and Technology in Health, Ottawa, ON, Canada., Irs A; State Agency of Medicines of Estonia, Tartu, Estonia; Heart Clinic, Tartu University Hospital, Tartu, Estonia., Akl EA; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon., Cuello CA; Michael G. DeGroote Cochrane Canada Centre and McMaster GRADE Centres, Department of Health Research Methods, Evidence, and Impact, Department of Medicine, and WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, ON, Canada; Canadian Agency for Drugs and Technology in Health, Ottawa, ON, Canada., Falavigna M; National Institute for Health Technology Assessment, Federal University of Rio Grande do Sul, Porto Alegre, Brazil., Gibbens M; Canadian Agency for Drugs and Technology in Health, Ottawa, ON, Canada., Neamtiu L; Joint Research Centre, European Commission, Ispra, Italy., Parmelli E; Joint Research Centre, European Commission, Ispra, Italy., Jameleddine M; Health Technology Assessment Department, National Authority for Assessment and Accreditation in Healthcare, Tunis, Tunisia., Pyke L; Canadian Agency for Drugs and Technology in Health, Ottawa, ON, Canada., Verstijnen I; Research and Development, International Affairs, National Health Care Institute, Diemen, Netherlands., Alonso-Coello P; Iberoamerican Cochrane Center, Biomedical Research Institute Sant Pau-CIBERESP, Barcelona, Spain; Centro GRADE Barcelona, Barcelona, Spain., Tugwell P; Department of Medicine, University of Ottawa, ON, Canada., Zhang Y; Michael G. DeGroote Cochrane Canada Centre and McMaster GRADE Centres, Department of Health Research Methods, Evidence, and Impact, Department of Medicine, and WHO Collaborating Center for Infectious Diseases, Research Methods and Recommendations, McMaster University, Hamilton, ON, Canada., Saz-Parkinson Z; Health Technology Assessment Agency, Instituto de Salud Carlos III, Madrid, Spain., Kuchenmüller T; Department of Research for Health, WHO, Geneva, Switzerland., Moja L; Department of Health Product Policy and Standards, WHO, Geneva, Switzerland.

Publikováno v: The Lancet. Public health [Lancet Public Health] 2022 Apr; Vol. 7 (4), pp. e378-e390.